跳至主要内容
临床试验/IRCT20231227060538N1
IRCT20231227060538N1尚未招募3 期

Investigating and comparing the effect of three therapeutic methods of Naproxen, hydroxyzine and Syrup Noscough as therapeutic methods for treatment of the bone pain caused by granulocyte-colony stimulating factor(GCSF) in cancer patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 123 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
123

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • patients with solid tumor or lymphoma Candidate for receiving Pegfilgrastim -after chemotherapy based on well known chemotherapy protocol

排除标准

  • Bone metastasis in patients with progression free survival(PFS )greater than 2
  • Test-proven osteomalacia
  • chronic kidney disease or end stage renal disease patients
  • Patients with active rheumatic disease
  • Uncontrolled thyroid disease
  • Patients receiving chemotherapy drugs in which bone pain is one of the complications with a high incidence of 10% (TAXAN family, bisphosphonate.)
  • Patients with pathological fracture or fracture due to any other reason
  • Opioid addicts
  • Contraindications for taking naproxen and methadone and other similar drugs
  • Vitamin D level less than 20
  • Paget's disease
  • Hyperparathyroid disease
  • Patients who have bone pains in the questionnaire with a score above 6 since the beginning of the project
  • liver disease
  • Patients with a history of cardiac arrhythmia
  • Patients who do not have the appropriate admission to fill out the pain questionnaire

研究者

相似试验